ISAC - Instituto de Salud Cardiovascular Dr. Carlos Soledispa, Daule, Eucador.
Red Endocor, Machala, Eucador.
J Endovasc Ther. 2024 Dec;31(6):1257-1261. doi: 10.1177/15266028231161243. Epub 2023 Mar 25.
The objective of this case is to report an endovascular occlusion of an acquired vascular fistula using an Amplatzer Vascular Plug II. Also, it is to review the available literature on risk factors, pathophysiology, and related management strategies about complications of the tunneled central venous catheter (TCVC).
The case was a 40-year-old man with a chronic kidney disease (CKD) on dialysis and with a history of several previous TCVC placements, along with recurrent infections. The last TCVC developed a fistula between the superior vena cava and the right pulmonary artery, shown by computed tomography (CT). We decided to remove a long-term TCVC and occluded the fistula applying an endovascular embolic device, an Amplatzer Vascular Plug II, subsequently. The patient was given parenteral treatment during 10 days of hospitalization. Over 9 months of follow-up, the device was appropriately positioned and did not obstruct the vascular flow.
Tunneled central venous catheters are frequently used for hemodialysis in patients in the last stage of CKD who do not have an arteriovenous fistula. Occasionally, delayed complications such as adherence or catheter migration occur. This case illustrates an endovascular treatment with excellent results and low risk of morbidity and mortality.
The purpose of this work is to present an endovascular occlusion by means of an Amplatzer® Vascular Plug II in a residual fistula. The endovascular way is decided in situations, for instance, once the cardiothoracic surgeons argue that the patient is not in general conditions to tolerate surgery, the surgical procedure would be complex, or, in a surgical approach with a difficult-to-resolve hemorrhage. We explain the technique and the materials we used for an excellent result and a low risk of complications. This case is intended to serve as an aid in the treatment of similar events.
本病例报告旨在使用 Amplatzer Vascular Plug II 对后天性血管瘘进行血管内闭塞。同时,回顾关于隧道式中心静脉导管(TCVC)并发症的危险因素、病理生理学和相关管理策略的现有文献。
患者为 40 岁男性,患有慢性肾脏病(CKD),正在接受透析治疗,曾多次放置 TCVC,并伴有反复感染。最后一根 TCVC 在上腔静脉和右肺动脉之间形成瘘管,这一情况通过计算机断层扫描(CT)显示出来。我们决定取出长期 TCVC,并使用血管内栓塞装置,即 Amplatzer Vascular Plug II 来闭塞瘘管。患者在住院期间接受了 10 天的静脉治疗。在 9 个月的随访期间,该装置位置适当,没有阻碍血管血流。
隧道式中心静脉导管在 CKD 晚期没有动静脉瘘的患者中常被用于血液透析。偶尔会出现迟发性并发症,如黏附或导管迁移。本例说明了一种血管内治疗方法,具有极好的效果,且发病率和死亡率低。
本研究的目的是介绍一种使用 Amplatzer® Vascular Plug II 对残留瘘管进行血管内闭塞的方法。在某些情况下,如心胸外科医生认为患者一般情况不能耐受手术、手术过程复杂、或手术过程中难以控制出血时,会选择血管内方法。我们解释了我们使用的技术和材料,以获得良好的效果和低并发症风险。本病例旨在为类似事件的治疗提供帮助。